Cross-reactive anti-PfCLAG9 antibodies in the sera of asymptomatic parasite carriers of Plasmodium vivax

Cross-reactive anti-PfCLAG9 antibodies in the sera of asymptomatic parasite carriers of Plasmodium vivax

Show other versions (1)

The PfCLAG9 has been extensively studied because their immunogenicity. Thereby, the gene product is important for therapeutics interventions and a potential vaccine candidate. Antibodies against synthetic peptides corresponding to selected sequences of the Plasmodium falciparum antigen PfCLAG9 were...

Full description

Bibliographic Details
Main Authors: Joana D'Arc Neves Costa, Fernando Berton Zanchi, Francisco Lurdevanhe da Silva Rodrigues, Eduardo Rezende Honda, Tony Hiroschi Katsuragawa, Dhélio Batista Pereira, Roger Lafontaine Mesquita Taborda, Mauro Shugiro Tada, Ricardo de Godoi Mattos Ferreira, Luiz Hildebrando Pereira-da-Silva
Format: Article
Language:English
Published: Instituto Oswaldo Cruz, Ministério da Saúde 2013-02-01
Series:Memórias do Instituto Oswaldo Cruz.
Subjects:
malaria
immunity
Amazon
cross-reaction
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762013000100016

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762013000100016

Similar Items